Research

#Covid-19 #Healthcare #Immunology / Virology & Vaccines #Public health #Research

NIH scientists urge pursuit of universal coronavirus vaccine 

Physician-scientists of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have published a paper in The New England Journal of Medicine which suggests that in order to counter future coronavirus outbreaks, the global scientific and medical research community should focus… Read More

#News #Trending News

#Clinical trials #Covid-19 #Healthcare #Research

First UK trial to assess use of antivirals to treat Covid-19 set to begin 

The first clinical trial in the UK to investigate whether antiviral drugs could help reduce the severity of Covid-19 is due to start, led by the University of Oxford and delivered in Wales by Cardiff University in partnership with Public Health Wales and Health and Care Research Wales. Cardiff University staff… Read More

#News

#Collaboration #Covid-19 #Research

Can this chewing gum reduce SARS-CoV-2 transmission? 

According to a new study, scientists have found chewing gum laced with a plant-grown protein serves as a “trap” for the SARS-CoV-2 virus, reducing viral load in saliva and potentially tamping down transmission.  The study  The work, led by Henry Daniell at the University of Pennsylvania’s School… Read More

#Covid-19 #News

#Covid-19 #Monoclonal antibodies #Reagents #Research

Sino Biological launches panel of research reagents for Omicron variant

Sino Biological has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus. The new Omicron product line includes recombinant Omicron spike proteins (RBD, S1, and S-ECD trimer), monoclonal antibodies recognising the Omicron spike protein, and the Omicron pseudovirus assay CRO service. These… Read More

#News

#Biopharma #Biotechnology #Drug innovation #Pharmaceuticals #Report #Research

Pharmaceuticals and biotech lead UK university innovation 

University technology and innovation is driving the UK's status in pharmaceuticals and biotechnology, according to GovGrant’s University Spinouts Report 2021.  The report  According to the new report, the pharmaceuticals and biotechnology sector dominates the top ten spinout companies of the last decade, ranked by valuation. Pharma and biotech companies within the top… Read More

#News #Trends & Analysis

Human liver
#Cancer research #Drug development #Immunology / Virology & Vaccines #Liver disease #Research

Does Hepatitis B virus support the survival and growth of liver cancer? 

Researchers at the Francis Crick Institute and Universidade de Santiago de Compostela have identified how the hepatitis B virus (HBV) can support the survival and growth of liver cancer, with this process starting early in tumour development, in some instances up to 20 years before cancer diagnosis.  Context  Around… Read More

#Cancer Research #News

#Life sciences #Market reporting #Pharmaceuticals #Research

Horizons report finds biopharma leaders at a crossroads 

CRB has released an industry report based on survey responses from more than 500 industry leaders and with unique analysis from CRB’s life sciences subject matter experts.  What is in the report?  Warp speed delivery: Speed to market is a more significant business driver in… Read More

#News

#AI / data analytics / healthtech / informatics #AstraZeneca #Drug development #Funding #Research #Technology

Next wave of innovation: AstraZeneca £1bn R&D centre 

AstraZeneca has unveiled The Discovery Centre (DISC) in Cambridge, UK – a research and development (R&D) facility designed to the world’s highest environmental standards and accommodating over 2,200 research scientists.  The new £1 billion facility will include advanced robotics, high-throughput screening and AI-driven technology. It will support AstraZeneca’s focus… Read More

#News

#Cancer research #Clinical trials #Rare disease #Research

Accelerating research: the path forward for treating rare cancers 

Listen to this article on the DDW Podcast: RareCan is a new company based in the UK. Its aim is to accelerate research into rare cancers. However, finding suitable patients willing to take part in research and trials of new drugs is difficult, which impacts the discovery process. Professor Andy Hall, Founding Director and… Read More

#Cancer Research #Editor's Choice #Exclusive Content #News #Opinion

#Collaboration #Covid-19 #Research

This week in drug discovery (15-19 November) 

News round-up by DDW’s Megan Thomas for 15-19 November  As the world emerges from the Covid-19 pandemic, DDW’s Megan Thomas has rounded up five stories which show how the drug discovery industry has used what it has learnt over the last two years to innovate for the… Read More

#News #Trending News

#Clinical trials #CRO #Pharmaceuticals #Research

Advantages of working with CROs in Central and Eastern Europe 

Discover how Central and Eastern Europe (CEE) provides an attractive environment to conduct clinical studies of any phase while partnered with a local CRO in this interview with Research Professionals’ Managing Partner, György Barta (DPharm).  Barta discusses the many benefits of conducting clinical studies in CEE as… Read More

#News

#Biology #Collaboration #Covid-19 #Research

CN Bio and iiCON announce Covid-19 research collaboration

CN Bio has entered a research collaboration with the Infection Innovation Consortium (iiCON) to validate the next generation of Covid-19 research tools.  iiCON’s £174 million programme brings together industry, academia, and clinicians to accelerate the discovery, development and deployment of new treatments and products. Led by the Liverpool School of… Read More

#Covid-19 #News #Trending News

#Antivirals #Covid-19 #Research

How will this anti-viral nasal spray protect against Covid-19? 

Birmingham Biotech and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against Covid-19. The formulation was engineered by Professor Liam Grover, from the university’s Healthcare Technologies Institute, and a team of researchers who also collaborated on its testing.  Covid-19… Read More

#Covid-19 #News

#Covid-19 #Drug design #Drug discovery #Immunology / Virology & Vaccines #Research #T-Cells

T-cell discovery could lead to new type of Covid-19 vaccines 

A study has found that some people are able to clear the Covid-19 virus quickly due to strong immune response from existing T-cells, which could lead to a new generation of vaccine development.   In a study published in Nature, researchers found that individuals with potential exposure to… Read More

#Covid-19 #News #Trending News

#Biology #Data #Drug discovery #Metabolomics #Precision medicine #Research

New metabolomics solution enables understanding of the microbiome 

Metabolon’s first offering from its SmartPanel portfolio aims to provide drug discovery and precision medicine researchers with a novel, dynamic process to explore biologically relevant views of metabolomic data in the context of specific metabolic pathways, biological themes, and disease associations.  “The metabolome offers a window into human… Read More

#Editor's Choice #News #Trending News